Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3065 |
|
| Actual shortage: | 232 (8%) | |
| Anticipated shortage: | 15 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2809 (92%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-RALOXIFENE | 60MG | TABLET | Resolved | 2023-01-13 | 2023-04-21 | 181104 |
| APO-METHYLPHENIDATE ER | 18MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-01-13 | 2023-04-21 | 181107 |
| APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2023-04-06 | 2023-04-27 | 188976 |
| APO-CARVEDILOL | 12.5MG | TABLET | Resolved | 2023-03-16 | 2023-04-27 | 187223 |
| APO-METHYLPHENIDATE ER | 27MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-03-02 | 2023-04-27 | 185927 |
| APO-OXYBUTYNIN | 5MG | TABLET | Resolved | 2023-03-16 | 2023-04-27 | 187229 |
| APO-OXYBUTYNIN | 5MG | TABLET | Resolved | 2023-02-02 | 2023-04-27 | 183474 |
| APO-VARENICLINE | 1MG | TABLET | Resolved | 2023-04-21 | 2023-04-27 | 190014 |
| APO-PANTOPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-03-02 | 2023-04-27 | 185936 |
| APO-RASAGILINE | 1MG | TABLET | Resolved | 2023-03-16 | 2023-04-27 | 187244 |
| APO-ROSUVASTATIN | 40MG | TABLET | Resolved | 2023-03-23 | 2023-04-27 | 187730 |
| APO-METHYLPHENIDATE | 10MG | TABLET | Resolved | 2023-03-23 | 2023-04-27 | 187724 |
| APO-AMIODARONE TABLETS | 200MG | TABLET | Resolved | 2023-03-23 | 2023-05-06 | 187727 |
| APO-CITALOPRAM | 40MG | TABLET | Resolved | 2023-03-23 | 2023-05-06 | 187721 |
| APO-CLOPIDOGREL | 75MG | TABLET | Resolved | 2023-04-21 | 2023-05-06 | 189994 |
| APO-DIVALPROEX | 250MG | TABLET (DELAYED-RELEASE) TABLET (ENTERIC-COATED) | Resolved | 2023-04-27 | 2023-05-06 | 190846 |
| APO-LEVOCARB-TAB 25MG/100MG | 100MG 25MG | TABLET | Resolved | 2023-04-14 | 2023-05-06 | 189632 |
| APO-NAPROXEN | 500MG | TABLET | Resolved | 2023-03-02 | 2023-05-06 | 185942 |
| APO-NAPROXEN | 500MG | TABLET | Resolved | 2023-02-23 | 2023-05-06 | 185459 |
| APO-ROSUVASTATIN | 40MG | TABLET | Resolved | 2023-04-27 | 2023-05-06 | 190865 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-NITROGLYCERIN | 0.4MG | METERED-DOSE PUMP | Discontinued | 2018-02-26 | 2018-02-26 | 40947 |
| APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 40957 |
| APO-ZOLMITRIPTAN | 2.5MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 40960 |
| APO-FLUNISOLIDE NASAL SPRAY | 0.25MG | METERED-DOSE PUMP | Discontinued | 2018-02-26 | 2018-02-26 | 40965 |
| APO-GAIN LIQ 20MG/ML | 20MG | SOLUTION | Discontinued | 2018-02-26 | 2018-02-26 | 40997 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41047 |
| APO DIMENHYDRINATE TAB 50MG | 50MG | TABLET | Discontinued | 2018-02-23 | 2018-02-28 | 40835 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
| APO DIMENHYDRINATE TAB 50MG | 50MG | TABLET | Discontinued | 2018-02-23 | 2018-05-07 | 40838 |
| APO-TELMISARTAN/HCTZ | 25MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-05-07 | 40829 |
| APO-TELMISARTAN/HCTZ | 25MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-05-07 | 40832 |
| APO-CETIRIZINE | Discontinued | 2018-05-31 | 2018-05-31 | 50998 | ||
| APO-SALVENT TABLETS - 4MG | 4MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40847 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-ATORVASTATIN | 10MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60276 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
| APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |